Covered recipient · General Payments record
DARCIE ENGLER RICHARDSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$645.39
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $471.01 | 12 |
| Education | $106.89 | 2 |
| Travel and Lodging | $3.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $203.09 | 5 |
| Astellas Pharma US Inc | $123.87 | 2 |
| Amgen Inc. | $111.74 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.80 | 2 |
| EISAI INC. | $41.67 | 2 |
| Acerta Pharma LLC | $39.23 | 2 |
| Tempus AI, Inc | $19.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $111.74 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117666197 | CMS |
| Astellas Pharma US Inc | $89.99 | 06/27/2024 | Education | Undisputed | 01/23/2026 | 1139502190 | CMS |
| Astellas Pharma US Inc | $33.88 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139558891 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.65 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105865686 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.58 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105786458 | CMS |
| Eisai Inc. | $16.90 | 03/06/2024 | Education | Undisputed | 01/23/2026 | 1110799197 | CMS |
| Eisai Inc. | $24.77 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110799199 | CMS |
| Lilly USA, LLC | $80.86 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135564306 | CMS |
| Lilly USA, LLC | $3.50 | 02/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135602021 | CMS |
| Lilly USA, LLC | $8.33 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135564308 | CMS |
| Lilly USA, LLC | $89.25 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135625133 | CMS |
| Lilly USA, LLC | $21.15 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135632592 | CMS |
| Novartis Pharmaceuticals Corporation | $21.70 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087336563 | CMS |
| Novartis Pharmaceuticals Corporation | $21.10 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087336565 | CMS |
| Tempus AI, Inc | $19.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150186328 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.